Website
http://dataportal.arc.gov.au/NCGP/API/grants/LP0990480
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Characterisation of the anti-inflammatory pathway targeted by chaperonin 10 (Cpn10). Diseases associated with excessive or inappropriate inflammation represent an enormous socioeconomic burden, and there is currently an urgent need to identify new targets for the development of more efficacious and safe treatments. This research seeks to provide such targets. The research may also lead to improvements in chaperonin 10 (Cpn10) treatment, which has already showing marked success in chronic inflammatory disease trials. Importantly, Cpn10 appears to be anti-inflammatory rather than immunosuppressive; a critical advantage over many current anti-inflammatory interventions. Immunosuppression can lead to increased infections, which can have serious consequences, especially in elderly patients.Funded Activity Details
Start Date: 07-2009
End Date: 12-2014
Funding Scheme: Linkage Projects
Funding Amount: $320,000.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Autoimmunity | Medical Biochemistry: Proteins And Peptides | Immunology | Immunology Not Elsewhere Classified
